Table 2.
Demographic and baseline characteristics of patients with localized scleroderma (LS).
| Characteristics | |
|---|---|
| Total | 36 |
| Female, n (%) | 25 (70) |
| White, n (%) | 34 (94.4) |
| LS subtype, n (%) | |
| Linear extremity | 12 (33.3) |
| Linear face/scalp | 6(16.7) |
| Generalized morphea | 5(13.9) |
| Mixed (linear and GM) | 7(19.4) |
| Subcutaneous morphea | 3 (8.3) |
| Plaque morphea | 3 (8.3) |
| Age at onset, yrs, median (IQR) | 7.86(4.63–11.91) |
| Age at last followup, yrs, median (IQR) | 13.15(9.89–16.61) |
| Disease duration before therapy started, mo, median (IQR) | 19.15(8.96–35.35) |
| Duration of followup, mo, median (IQR) | 36.40 (29.39–45.36) |
GM: generalized morphea; IQR: interquartile range.